Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03191344
Other study ID # IPSS
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 1, 2017
Est. completion date July 1, 2019

Study information

Verified date September 2018
Source Fujian Medical University
Contact BO WANG, MS
Phone 13705947900
Email wangbo@fjmu.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

after established the Intraoperative Parathyroid Scores System (IPSS) for thyroidectomy we further extented the clinical value of Intraoperative Parathyroid Scores System in Treatment decisions of calcium treatment time and improve recognition skills of parathyroid in Clinicians


Description:

IPSS includes transplantation Parathyroid Scores and in situ Parathyroid Scores, the investigators will establish the Intraoperative Parathyroid Scores System by parathyroid size and Blood supply, and recording IPSS, according to certain rules. We expand IPSS, including the description of the location of parathyroid after postoperative.Parathyroid hormone and calcium were test in d0, d1, d14, d60 post operation. The correlation between Intraoperative Parathyroid Scores and PTH calcium were calculated, and ROC curve and logistic regression were tested for the prediction value.and after that we further evaluate the relationship Between IPSS and calcium supplement time.and Whether IPSS enhance ability of parathyroid recognition for clinical doctors.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date July 1, 2019
Est. primary completion date July 1, 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 60 Years
Eligibility Inclusion Criteria:

1. postoperative pathology confirmed as thyroid papillary carcinoma;

2. for the first time to undergo thyroid surgery, no history of neck surgery and external radiotherapy;

3. preoperative serum calcium, parathyroid hormone levels were normal;

4. intraoperative and postoperative clinical data integrity, standardized follow-up patients;

5. parathyroid is a tumor violation.

Exclusion Criteria:

1. serious underlying disease;

2. age greater than 60 years of age or combined with arteriosclerotic disease;

3. patients with postoperative loss;

4. patients with parathyroid disease.

Study Design


Related Conditions & MeSH terms

  • Intraoperative Parathyroid Scores System

Intervention

Behavioral:
with IPSS
all patient in one group use IPSS to record the parathyroid status. the other group operation as ordinary. record the parathyroid status in verbal description

Locations

Country Name City State
China Wen-xin ZHAO Fuzhou Fujian

Sponsors (1)

Lead Sponsor Collaborator
Fujian Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other The Predictive Value of IPSS for Intravenous and Oral Calcium duration Comparison of the correlation between IPSS values and intravenous calcium supplementation and oral calcium supplementation time. 1 year
Primary Differences of parathyroid records between IPSS and TD The percentage of recorded integrity of the parathyroid gland and the number of recognizable parathyroids were compared between the two groups. 1 year
Secondary The effect of IPSS on the level of parathyroid recognition of surgeons Comparison of the number of parathyroid gland found in the pathology and the number of postoperative hypoparathyroidism between the two groups 1 year
Secondary differences of the number of parathyroid glands found in the pathology betwen IPSS and TD differences of the number of parathyroid glands found in the pathology betwen IPSS and TD 1 year
See also
  Status Clinical Trial Phase
Completed NCT03172312 - Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy N/A